LFPI.US LifePoint Inc
- Market cap
- USD 146K
- P/E
- -
- P/B
- 0.00x
- ROE
- -178.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Dec 2004.
Is LFPI.US undervalued?
Graham numberThe Graham number of LifePoint Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LifePoint Inc fundamental analysis
No fundamental analysis for LifePoint Inc yet.
LifePoint Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About LifePoint Inc
LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. It serves workplaces, ambulances, pharmacies, law enforcements, and home health care markets. LifePoint, Inc. was formerly known as US Drug Testing, Inc. and changed its name to LifePoint, Inc. in February 1998. The company was incorporated in 1992 and is based in Ontario, California.
Full company profileLifePoint Inc financial statements
2004 annualized: Fiscal year 2004 is not finished. Income statement and cash flow are annualized from 3 quarters up to Dec 31, 2004, the balance sheet is the latest quarter. Figures change when the annual report is published.
LifePoint Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2004 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 1.00 | 1.00 | 1.00 | 136K | 48.7K | -18.5K | 109K |
| Gross Profit | 1.00 | 1.00 | 1.00 | -487K | -1.27M | -71.4K | -3.30M |
| Operating Income | -2.74M | -4.07M | -7.59M | -12.8M | -15.7M | -7.50M | -9.01M |
| EBITDA | -2.60M | -3.97M | -7.33M | -12.3M | -14.8M | -14.2M | -8.54M |
| Net Income | -2.70M | -3.95M | -7.16M | -12.6M | -16.1M | -15.2M | -9.50M |
| EPS | -0.23 | -0.26 | -0.23 | -0.40 | -0.45 | -0.36 | -0.10 |
| Balance Sheet | |||||||
| Total Assets | 5.06M | 10.1M | 9.07M | 7.58M | 5.91M | 8.81M | 6.92M |
| Total Liabilities | 630K | 907K | 2.38M | 3.37M | 5.98M | 2.45M | 1.59M |
| Shareholders' Equity | 4.43M | 9.17M | 6.69M | 4.21M | -68.9K | 6.36M | 5.32M |
| Cash & Short-term Investments | 4.80M | 9.48M | 6.23M | 2.99M | 75.6K | 3.71M | 2.19M |
| Total Debt | - | 101K | 1.22M | 796K | 2.42M | 447K | 187K |
| Cash Flow | |||||||
| Operating Cash Flow | -2.10M | -3.86M | -6.95M | -12.0M | -14.7M | -6.97M | -8.54M |
| Capital Expenditure | 6.79K | 90.8K | 710K | 728K | 729K | 142K | 57.0K |
| Free Cash Flow | -2.10M | -3.95M | -7.66M | -12.8M | -15.4M | -7.11M | -8.56M |
| Ratios | |||||||
| ROE | -60.9% | -43.1% | -107.1% | -299.1% | - | -239.7% | -178.4% |
| ROA | -53.3% | -39.2% | -79.0% | -166.2% | -271.9% | -172.9% | -137.3% |
| Net Profit Margin | -269,671,300.0% | -394,978,400.0% | -716,252,900.0% | -9,263.8% | -32,983.4% | - | -8,697.9% |
| Debt to Equity | - | 0.01x | 0.18x | 0.19x | - | 0.07x | 0.04x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
LifePoint Inc dividends
LifePoint Inc has not paid dividends in the last 6 fiscal years.
Who owns LifePoint Inc
Ownership data of LifePoint Inc is not available yet.
LifePoint Inc company profile
- Company name
- LifePoint Inc
- Ticker
- LFPI.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 52
- Fiscal year end
- March
- Address
- 1205 South Dupont Street, Ontario, CA, United States, 91761
- Phone
- 909-418-3000
- Website
- lifepointinc.org
About LifePoint Inc
LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. It serves workplaces, ambulances, pharmacies, law enforcements, and home health care markets. LifePoint, Inc. was formerly known as US Drug Testing, Inc. and changed its name to LifePoint, Inc. in February 1998. The company was incorporated in 1992 and is based in Ontario, California.
LifePoint Inc management
1- Mr. M. Richard WadleyCEO & President · born 1946